Search

everythinglearnresearchcommunity

for

Search:↓

PPCM microspheres allow controlled finasteride release over 24 hours.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Finasteride cream reduces hair growth in women with hirsutism, but more research needed.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Acne is an important sign of androgen excess disorders in women.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.

Children's hairlines change shape as they grow, with women often developing a widow's peak and men's hairlines becoming more convex and possibly balding at the temples, influenced by genetics and hormones.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

Nanostructured lipid carriers are promising for improving drug delivery in medicine and food.

People with vitiligo may have a lower risk of heart disease.